FDA Updates Regulations to Advance Alternatives to Animal Testing

HHS issues direct final rule to reduce reliance on animal testing

FDA has issued a direct final rule that changes the language in its regulations so that “animal testing” is no longer described as the default or defining form of “nonclinical” safety testing.  This content is for Individual Subscription - Monthly ($55), Individual Subscription - Annual ($555), Introductory Subscription - non-renewing ($60), Group 1 - Individual Seat, and Sponsored account members only. Visit the site and log in/register to read.

Rep. Barragán Applauds FDA Action Advancing Non-Animal Testing Methods

WASHINGTON, D.C. — Rep. Nanette Barragán (CA-44) Sept. 21 welcomed the U.S. Food and Drug Administration’s issuance of a direct final rule, which updates federal regulations to clarify scientifically appropriate non-animal methods can be used to evaluate the safety of drugs and biological products before they are tested in humans. The FDA’s action follows bipartisan […] The post Rep. Barragán Applauds FDA Action Advancing Non-Animal Testing Meth…

FDA Updates Regulations to Advance Alternatives to Animal Testing

FDA Updates Regulations to Expand Use of Innovative Alternatives to Animal Testing New rule clarifies that validated non-animal methods can be used in drug and biologics development while maintaining existing safety standards The U.S. Food and Drug Administration (FDA) has issued a direct final rule updating its regulations to clarify that non-animal methods can be […] The post FDA Updates Regulations to Advance Alternatives to Animal Testing ap…